Shares of Microbix Biosystems Inc. (TSE:MBX – Get Free Report) passed above its 50 day moving average during trading on Monday . The stock has a 50 day moving average of C$0.37 and traded as high as C$0.44. Microbix Biosystems shares last traded at C$0.43, with a volume of 358,656 shares traded.
Microbix Biosystems Stock Performance
The company’s 50 day simple moving average is C$0.37 and its 200 day simple moving average is C$0.35. The stock has a market cap of C$58.78 million, a PE ratio of 10.75 and a beta of 0.34. The company has a debt-to-equity ratio of 22.68, a quick ratio of 5.57 and a current ratio of 6.62.
Microbix Biosystems Company Profile
Microbix Biosystems Inc, a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company manufactures diagnostic-test products, such as test-controls under the QAPs brand; viral transport medium for collection of patient samples to test for pathogens including virus causing the COVID-19 disease under the DxTM brand; Kinlytic, a biologic thrombolytic drug used to treat blood clots; and antigen products.
Recommended Stories
- Five stocks we like better than Microbix Biosystems
- How to Invest in Insurance Companies: A Guide
- 3 Stocks to Gain From Donald Trump’s External Revenue Service
- Diversification Can Smooth Returns And Mitigate Portfolio Risk
- AMD: Loop Capital’s Buy Rating Reinforces Investor Confidence
- 3 Stocks to Consider Buying in October
- Momentum Is Building for Qualcomm to Have a Strong Run in 2025
Receive News & Ratings for Microbix Biosystems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Microbix Biosystems and related companies with MarketBeat.com's FREE daily email newsletter.
